Literature DB >> 27461582

Modifiable and non-modifiable risk factors for pancreatic cancer: A review.

Shallu Midha1, Saurabh Chawla2, Pramod Kumar Garg3.   

Abstract

Pancreatic ductal adenocarcinoma is associated with a poor prognosis and a high case-fatality rate. The reasons for poor prognosis are low rates of curative resection due to local infiltration and distant metastasis. To increase survival rates of patients with pancreatic cancer, early detection through surveillance and screening is important. However, screening could only be cost-effective in high-risk populations. Identification of significant risk factors therefore assumes significance. Risk factors could be non-modifiable or modifiable. Non-modifiable risk factors include increasing age, familial cancer syndromes, Afro-American race, hereditary and other forms of chronic pancreatitis, diabetes, and non-O blood group. Important modifiable risk factors include smoking, obesity, dietary factors such as non-vegetarian diet, and toxins. Preventive strategies at the population level and an effective screening program targeted at high-risk people may help in prevention and early detection of pancreatic ductal adenocarcinoma.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Chronic pancreatitis; Familial; Pancreatic cancer; Risk factors; Smoking

Mesh:

Substances:

Year:  2016        PMID: 27461582     DOI: 10.1016/j.canlet.2016.07.022

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  58 in total

1.  Mouse Pancreatic Tumor Model Independent of Tumor Suppressor Gene Inactivation.

Authors:  Mayumi Naramura; Amarnath Natarajan
Journal:  Pancreas       Date:  2018 May/Jun       Impact factor: 3.327

Review 2.  Cellular determinants and therapeutic implications of inflammation in pancreatic cancer.

Authors:  Meredith L Stone; Gregory L Beatty
Journal:  Pharmacol Ther       Date:  2019-05-31       Impact factor: 12.310

3.  Induction of endoplasmic reticulum stress by aminosteroid derivative RM-581 leads to tumor regression in PANC-1 xenograft model.

Authors:  Martin Perreault; René Maltais; Jenny Roy; Sylvain Picard; Ion Popa; Nicolas Bertrand; Donald Poirier
Journal:  Invest New Drugs       Date:  2018-07-30       Impact factor: 3.850

4.  Modified FOLFIRINOX in pancreatic cancer patients Age 75 or older.

Authors:  Jonathan D Mizrahi; Jane E Rogers; Kenneth R Hess; Robert A Wolff; Gauri R Varadhachary; Milind M Javle; Rachna T Shroff; Linus Ho; David R Fogelman; Kanwal P S Raghav; Michael J Overman; Shubham Pant
Journal:  Pancreatology       Date:  2020-01-09       Impact factor: 3.996

5.  Abrogation of glutathione peroxidase-1 drives EMT and chemoresistance in pancreatic cancer by activating ROS-mediated Akt/GSK3β/Snail signaling.

Authors:  Qingcai Meng; Si Shi; Chen Liang; Dingkong Liang; Jie Hua; Bo Zhang; Jin Xu; Xianjun Yu
Journal:  Oncogene       Date:  2018-07-06       Impact factor: 9.867

6.  Prior History of Pancreatitis Accelerates the Development of Pancreatic Adenocarcinoma.

Authors:  Anna Evans Phillips; Nilesh Shah; Amir A Borhani; Dhiraj Yadav; Randall E Brand
Journal:  Pancreas       Date:  2018 Nov/Dec       Impact factor: 3.327

7.  Activation of PPARα by clofibrate sensitizes pancreatic cancer cells to radiation through the Wnt/β-catenin pathway.

Authors:  J Xue; W Zhu; J Song; Y Jiao; J Luo; C Yu; J Zhou; J Wu; M Chen; W-Q Ding; J Cao; S Zhang
Journal:  Oncogene       Date:  2017-10-23       Impact factor: 9.867

8.  Influence of the body mass index on postoperative outcome and long-term survival after pancreatic resections in patients with underlying malignancy.

Authors:  Philippa Seika; Fritz Klein; Uwe Pelzer; Johann Pratschke; Marcus Bahra; Thomas Malinka
Journal:  Hepatobiliary Surg Nutr       Date:  2019-06       Impact factor: 7.293

Review 9.  Burden of Pancreatic Cancer: From Epidemiology to Practice.

Authors:  Natalia Khalaf; Hashem B El-Serag; Hannah R Abrams; Aaron P Thrift
Journal:  Clin Gastroenterol Hepatol       Date:  2020-03-06       Impact factor: 11.382

10.  Diabetes risk reduction diet and the risk of pancreatic cancer.

Authors:  Federica Turati; Marta Rossi; Veronica Mattioli; Francesca Bravi; Eva Negri; Carlo La Vecchia
Journal:  Eur J Nutr       Date:  2021-08-02       Impact factor: 5.614

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.